GlassScriptPhysician profile
Ruth Bochat
NPI 1124618228
$22,615.30
in general payments reported to CMS, 2019-2025
33 companies · $6,066 in 2025
The $6,066 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.19 · 2022: $3,917 · 2023: $5,299 · 2024: $7,247 · 2025: $6,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $4,279 · Consulting Fee: $690 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90.00 · Entertainment: $32.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,519.51 |
| Travel and Lodging | $4,279.01 |
| Consulting Fee | $690.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90.00 |
| Entertainment | $32.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,380.46 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Mml US, INC. | $4,779.83 | 2022-2025 | Reactiv8 |
| Relievant Medsystems, INC. | $2,691.42 | 2022-2023 | Intracept |
| Saluda Medical Americas, INC. | $2,017.02 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $1,734.55 | 2024-2025 | Nalu Neurostimulation System |
| Foundation Fusion Solutions, LLC | $1,350.17 | 2024-2025 | |
| Abbott Laboratories | $966.68 | 2023-2025 | Proclaim, Eterna |
| Nevro Corp. | $320.71 | 2022-2024 | Senza |
| Medtronic, INC. | $305.96 | 2024 | Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $219.69 | 2025 | Prospera |
| Spinal Simplicity, LLC | $181.11 | 2025 | Ha Minuteman G3-R |
| Si-Bone, INC. | $174.29 | 2025 | |
| Spr Therapeutics, INC | $157.54 | 2022-2025 | Sprint Pns System |
| Stryker Corporation | $152.06 | 2023 | Omnicurve |
| Inspire Medical Systems, INC. | $123.42 | 2024 | Inspire |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $117.76 | 2023 | Qutenza |
| Djo, LLC | $114.94 | 2024 | Cmf |
| Curonix LLC | $114.94 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $113.51 | 2022 | |
| Collegium Pharmaceutical, INC. | $103.16 | 2021-2023 | Xtampza |
| Vertos Medical, INC. | $81.83 | 2024 | Mild Device Kit |
| Forte Bio-Pharma LLC | $73.49 | 2021-2023 | Prolate, Nalocet |
| Abbvie INC. | $61.87 | 2022-2024 | |
| Highridge Medical LLC | $45.64 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Biohaven Pharmaceutical Holding Company LTD. | $44.55 | 2022 | |
| Scilex Pharmaceuticals INC. | $37.77 | 2022 | |
| Protega Pharmaceutials INC | $33.28 | 2025 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.20 | 2021-2022 | |
| Horizon Therapeutics Plc | $20.50 | 2022 | |
| Almatica Pharma LLC | $18.37 | 2022 | |
| Spineology INC. | $16.69 | 2025 | Optimesh Expandable Interbody Fusion System |
| Lundbeck LLC | $15.34 | 2021 | |
| Bioventus LLC | $13.55 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Bochat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.